Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (Q58947783)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 November 2009

Language	Label	Description	Also known as
English	Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease	scientific article published on 18 November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

atherosclerosis

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

Giuseppina Basta

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Carmine Zoccali

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Raffaele De Caterina

9

object named as

Raffaele De Caterina

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Daniela Leonardis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Francesca Mallamaci

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sebastiano Cutrupi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Patrizia Pizzini

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lorena Gaetano

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Rocco Tripepi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Giovanni Tripepi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

0 references

publication date

18 November 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Kidney International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

77

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

225-231

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

https://scigraph.springernature.com/pub.10.1038/ki.2009.419

0 references

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products: sparking the development of diabetic vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble receptor for advanced glycation end products in patients with decreased renal function.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between nutrition and inflammation in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

The concept of ventricular/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Are advanced glycation end products cardiovascular risk factors in patients with CRF?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products and mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Pregnancy-Associated Plasma Protein A and Soluble Receptor for Advanced Glycation End Products after Kidney Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.419

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/KI.2009.419

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19924100%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58947783&oldid=1818413327"